Considering Mycological Rarities
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

Considering Mycological Rarities

Filetype[PDF-1.91 MB]



Details:

  • Alternative Title:
    Emerg Infect Dis
  • Personal Author:
  • Description:
    Mattia di Nanni di Stefano (1403–1433), Scipio Africanus ca. 1425–1430. Poplar, bog oak and other wood inlay, rosewood, tin, bone, traces of green coloring, 24.19 in x 17.13 in/61.5 cm x 43.3 cm. Public domain image courtesy of The Metropolitan Museum of Art, New York, NY, USA.

    Neither plant nor animal, fungal organisms―in- cluding lichen, mildew, mushrooms, molds, rusts, smuts, and yeasts―are found in nearly every possible terrestrial habitat, even aboard the Interna- tional Space Station. There are millions of species of fungi, and according to the Centers for Disease Con- trol and Prevention, a few hundred fungal species cause illness in people, ranging from allergies and asthma, to skin rashes and infections, to deadly infec- tions of the bloodstream or lungs.

    In a 2013 EID article, Mary Brandt and Benjamin Park note the growing number of human infections from traditional and new fungal agents. Factors driv- ing this emergence, they explain, include medical treatments that make immunocompromised patients more susceptible. They also state that “Risk factors such as changes in land use, seasonal migration, inter- national travel, extreme weather, and natural disas- ters, and the use of azole antifungal agents in large- scale agriculture are believed to underlie many of the increases in community-acquired fungal infections.”

    The recent emergence of Candida auris infections, for instance, underscores those concerns on a broad scale because C. auris is often multidrug-resistant, dif- ficult to identify, and causes outbreaks in healthcare settings. A recent study from Finland that reported life-threatening fungal bloodstream infections associ- ated with consuming probiotic supplements that con- tain Saccharomyces boulardii reveals a route of infection that may represent another mycological issue.

  • Subjects:
  • Source:
  • Pubmed Central ID:
    PMC8386784
  • Document Type:
  • Volume:
    27
  • Issue:
    9
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

You May Also Like

Checkout today's featured content at stacks.cdc.gov